I-Relative Sensitivity: 95.60% (95% CI: 88.89% ~98.63%)
Iinkcukacha Ngokuhambelanayo: 100% (95% CI:98.78%～100.00%)
Ukuchaneka: 98.98% (95% CI:97.30%～99.70%)
Rtk antigen uvavanyo AMRDT121 iyathengiswa
Uvavanyo olukhawulezayo lokufunyanwa komgangatho we-antigens kwinoveli coronavirus i-SARS-CoV-2 emqaleni womntu kunye nokuphuma kweempumlo, kunye nomzekelo wamathe.
Ukusetyenziswa koxilongo lwe-in vitro kuphela.
Rtk antigen uvavanyo AMRDT121 UKUPAKA INKCAZO
40 T/kit, 20 T/kit, 10 T/kit, 1 T/kit.
Rtk antigen uvavanyo AMRDT121 UKUSETYENZISWA OKUHLOSIWEYO
UVavanyo oluKhawulezayo lwe-SARS-CoV-2 Antigen Rapid (COVID-19 Ag) luvavanyo olukhawulezayo lwe-chromatographic immunoassay yokufumanisa inoveli coronavirus i-SARS-CoV-2 emqaleni womntu kunye nokuphuma kweempumlo, kunye nesampulu yamathe.
Rtk antigen uvavanyo AMRDT121 UMGAQO
UVavanyo oluKhawulezayo lwe-SARS-CoV-2 lwe-Antigen olukhawulezileyo lolokubona ii-antigens ze-SARS-CoV-2.I-Anti-SARS-CoV-2 i-monoclonal antibodies ifakwe kumgca wovavanyo kwaye idityaniswe negolide ye-colloidal.Ngexesha lovavanyo, umzekelo uphendula kunye ne-anti-SARS-CoV-2 antibodies conjugate kumtya wovavanyo.
Umxube emva koko ufudukela phezulu kwi-membrane yechromatographical ngesenzo se-capillary kwaye uphendule kunye nenye i-Anti-SARS-CoV-2 ye-monoclonal antibodies kwindawo yovavanyo.I-complex ibanjwe kwaye yenze umgca onemibala kwindawo yovavanyo lovavanyo.
Uvavanyo lwe-antigen ye-Rtk i-AMRDT121 iqulethe i-anti-SARS-CoV-2 monoclonal antibodies conjugated particles kunye nezinye ezilwa ne-SARS-CoV-2 monoclonal antibodies zigqunywe kwimimandla yovavanyo.
Rtk antigen uvavanyo AMRDT121 UKUGCINWA NOZInzo
Ikiti ingagcinwa kwiqondo lokushisa okanye ifriji (2-30 ° C).I-Test Strip izinzile ngomhla wokuphelelwa kwexesha eliprintiweyo kwingxowa evaliweyo.I-Test Strip kufuneka ihlale kwisingxobo esivaliweyo de isetyenziswe.MUSA UKUMKHENZA.Musa ukusebenzisa ngaphaya komhla wokuphelelwa.Ukuzinza kwekiti phantsi kwale miqathango yokugcina iinyanga ezili-18
Uvavanyo lwe-antigen ye-RTk ye-AMRDT121 UKUQOKELELWA KOMPILO NOKULUNGISWA
UVavanyo oluKhawulezayo lwe-SARS-CoV-2 Antigen Rapid (COVID-19 Ag) lunokwenziwa kusetyenziswa incindi yomqala kunye nokuphuma kweempumlo.
Imifihlo yoMqala: Faka iswab engenazintsholongwane emqaleni.Gcoba ngobumnene iimfihlo ezijikeleze udonga lwe-pharynx.
Imifihlo yeempumlo: Faka iswayi engenazintsholongwane kumngxuma wempumlo onzulu.Jikelezisa ngobunono iswab kudonga lwe turbinate amaxesha amaninzi.Yenza i-swab ibe manzi kangangoko.
Amathe: Thatha isikhongozeli sokuqokelelwa komzekelo.Yenza ingxolo ethi "Kruuua" emqaleni, ukukhupha amathe okanye isikhohlela kumqala onzulu.Emva koko utshice amathe (malunga ne-1-2ml) kwisitya.Amathe akusasa alungele ukuqokelelwa kwamathe.Musa ukuxukuxa amazinyo, utye ukutya okanye usele phambi kokuba uqokelele isampuli yamathe.
Qokelela i-0.5ml ye-assay buffer kwaye uyibeke kwityhubhu yokuqokelela umzekelo.Faka i-swab kwi-tube kwaye ucinezele ityhubhu eguquguqukayo ukuze ukhuphe i-specimen ukusuka kwintloko ye-swab.
Yenza umboniso usonjululwe ngokwaneleyo kwisithinteli sovavanyo.Yongeza incam yekristale kwityhubhu yokuqokelela isampuli.Ukuba umfuziselo wamathe, munca amathe kwisikhongozeli kwaye ubeke amathontsi ama-5 (approx.200ul) amathe kwityhubhu yokuqokelela isampulu.
